Status:
RECRUITING
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
Lead Sponsor:
Invivoscribe, Inc.
Conditions:
Hematologic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research
Detailed Description
Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patie...
Eligibility Criteria
Inclusion
- Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
- Donor Age ≥ 18 years
Exclusion
- Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
- The specimens/samples have previously been enrolled in a clinical study
Key Trial Info
Start Date :
March 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06222164
Start Date
March 30 2024
End Date
June 30 2027
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LabPMM
San Diego, California, United States, 92121